Related Experiment Video

Updated: Jun 12, 2026

Induction and Analysis of Epithelial to Mesenchymal Transition
10:37

Induction and Analysis of Epithelial to Mesenchymal Transition

Published on: August 27, 2013

PTK6 inhibits down-regulation of EGF receptor through phosphorylation of ARAP1

Shin-Ae Kang1, Eun-Saem Lee, Hye-Young Yoon

  • 1Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul 120-749, Korea.

The Journal of Biological Chemistry
|June 18, 2010
PubMed

Insights

Protein tyrosine kinase 6 (PTK6) enhances breast cancer growth by stabilizing the epidermal growth factor receptor (EGFR). PTK6 phosphorylates ARAP1, preventing EGFR degradation and boosting signaling pathways crucial for tumor progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Protein tyrosine kinase 6 (PTK6) is a non-receptor tyrosine kinase overexpressed in breast carcinomas.
  • PTK6 plays a role in cancer cell signaling, but its interacting proteins and precise functions are not fully understood.

Purpose of the Study:

  • To identify proteins that interact with PTK6.
  • To elucidate the mechanism by which PTK6 influences epidermal growth factor receptor (EGFR) signaling in breast cancer.

Main Methods:

  • Co-immunoprecipitation assays using Flag-tagged PTK6 in HEK293 cells.
  • MALDI-TOF mass spectrometry for protein identification.
  • Site-directed mutagenesis to investigate the role of specific residues.
  • Western blotting to assess protein levels and signaling pathway modulation.

Main Results:

  • ARAP1 (centaurin delta-2) was identified as a PTK6-interacting protein.
  • PTK6 binds ARAP1 in an EGF/EGFR-dependent manner, requiring the SH2 domain of PTK6.
  • PTK6 phosphorylates ARAP1 at Tyr(231), which inhibits EGFR down-regulation.
  • ARAP1 expression, but not its Y231F mutant, prevented EGFR reduction in PTK6-expressing cells.
  • Silencing PTK6 decreased EGFR levels in breast cancer cells.

Conclusions:

  • PTK6 enhances EGFR signaling in breast cancer by inhibiting EGFR degradation via ARAP1 phosphorylation.
  • This PTK6-ARAP1-EGFR axis represents a potential therapeutic target for breast cancer treatment.

More Related Videos

Assaying Protein Kinase Activity with Radiolabeled ATP08:05

Assaying Protein Kinase Activity with Radiolabeled ATP

Published on: May 26, 2017

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death09:18

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death

Published on: December 27, 2016

Related Concept Videos

Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...